233 related articles for article (PubMed ID: 6170417)
21. Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
Nørgaard-Pedersen B; Schultz H; Arends J; Brincker H; Jacobsen GK; Lindeløv B; Rørth M; Svennekjaer IL
Ann N Y Acad Sci; 1983; 417():390-9. PubMed ID: 6200044
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic value of human chorionic gonadotrophin in patients with testicular seminoma.
Paus E; Fosså SD; Risberg T; Nustad K
Br J Urol; 1987 Jun; 59(6):572-7. PubMed ID: 3690188
[TBL] [Abstract][Full Text] [Related]
23. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Javadpour N; McIntire KR; Waldmann TA
Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
[TBL] [Abstract][Full Text] [Related]
24. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
[TBL] [Abstract][Full Text] [Related]
25. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
[TBL] [Abstract][Full Text] [Related]
26. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
[TBL] [Abstract][Full Text] [Related]
27. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
[TBL] [Abstract][Full Text] [Related]
28. Treatment of seminoma: does a positive HCG influence prognosis?
Bartsch G; Mikuz G; Frommhold H; Scheiber K
Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
[No Abstract] [Full Text] [Related]
29. [Testis cancer markers. Clinical use].
Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of stage I, II testicular tumor based on tumor markers].
Kamidono S; Arakawa S; Hamami G; Umezu K; Fujii A; Ishigami J
Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1383-93. PubMed ID: 6202917
[No Abstract] [Full Text] [Related]
31. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
[TBL] [Abstract][Full Text] [Related]
32. Testicular tumour markers in tissue correlated to serum levels and clinical stage.
Alm P; Hultberg B; Olsson AM
Scand J Urol Nephrol; 1984; 18(4):283-8. PubMed ID: 6209794
[TBL] [Abstract][Full Text] [Related]
33. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Dunzendorfer U; Jurincic C
Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Aass N; Klepp O; Cavallin-Stahl E; Dahl O; Wicklund H; Unsgaard B; Baldetorp L; Ahlström S; Fosså SD
J Clin Oncol; 1991 May; 9(5):818-26. PubMed ID: 1707957
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in metastatic testicular cancer.
Vogelzang NJ
Int J Androl; 1987 Feb; 10(1):225-37. PubMed ID: 2438220
[TBL] [Abstract][Full Text] [Related]
36. The role of biologic tumor markers in testicular cancer.
Javadpour N
Cancer; 1980 Apr; 45(7 Suppl):1755-61. PubMed ID: 6154517
[No Abstract] [Full Text] [Related]
37. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract][Full Text] [Related]
38. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
[TBL] [Abstract][Full Text] [Related]
39. Serum tumour markers in testicular and extragonadal germ cell malignancies.
Klepp O
Scand J Clin Lab Invest Suppl; 1991; 206():28-41. PubMed ID: 1947758
[TBL] [Abstract][Full Text] [Related]
40. Human chorionic gonadotropin-positive seminoma: is this a special type of seminoma with a poor prognosis?
Scheiber K; Mikuz G; Frommhold H; Bartsch G
Prog Clin Biol Res; 1985; 203():97-104. PubMed ID: 3832120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
